4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-24-022413
Co-Chief Executive Officer acquired 126,667 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Joshua B Co-Chief Executive Officer | 2024-02-26 | Grant or award | +126,667 | 3,027,137 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Joshua B Co-Chief Executive Officer | 2024-02-26 | Grant or award · Stock Option (right to buy) | +190,000 | 190,000 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…